Companies
-
AbbVie comms queen rises
- 05 May 2021
Kate Richards says while change is ‘everpresent’ in public affairs, this is much more evident in the new Covid world while Peta James and Kate Scott-Murphy take up new roles at GSK and Novartis.
Read more -
HTA young guns make their mark
- 03 May 2021
This trio of new recruits are diverse in background but say that’s what makes the magic work at high-powered consultancy HTAnalysts.
Read more -
MedTwos: Jenny and Karl Herz
- 28 Apr 2021
Power couple Jenny and Karl Herz run Biointelect and Biocelect, which are working with Novavax to bring its COVID-19 vaccine to Australia. In our first MedTwos, they talk about their 30-year partnership and what makes it work.
Read more -
Life in pharma like ‘opening a million doors’
- 21 Apr 2021
Bayer ANZ Medical Director Eduardo Pimenta’s Brazilian doctor father was not happy when his son took a job in pharma but with a career journey focused on patients, Dr Pimenta’s father is now a fan.
Read more -
GSK Covid drug arrives in Aust
- 16 Apr 2021
The first monoclonal antibody to treat Covid could be approved in days but will Aust be able to secure supply?
Read more -
Novartis’ 50/50 gene payment plan
- 14 Apr 2021
New gene therapy Luxturna for ultra-rare vision loss offered on a pay-for-performance deal, with half the cost paid upfront.
Read more -
Is MA’s Code ‘struggling for relevance’?
- 12 Apr 2021
Top Australian life sciences lawyer says MA’s principles-based code could hold companies to a ‘higher standard’ than previous versions.
Read more -
Patients up ante in compassionate access push
- 12 Apr 2021
Cystic Fibrosis Australia is not backing down on its request for immediate access for 2,000 patients should the PBAC recommend Vertex’ Trikafta.
Read more